Over the past few decades, the pharmaceutical industry in Australia has been struck by many challenges as well as been facing a lot of opportunities. This industry includes all companies that develop drugs and then patent and distribute the drugs to consumers.
The first part of this paper is a Porter’s Five Analysis of the pharmaceutical industry as a whole and a comparison between Australian pharmaceutical industries limited (API) and Primary Health Care Limited (PRY).
1. power of buyers
Australian pharmaceutical industries limited (API) and Primary Health Care Limited (PRY) are two companies that both operate in pharmaceutical industry. Both of their operations involve a large number and a wide range of buyers. These buyers are mainly comprised of various pharmacies, hospitals, doctors, pharmacists, individuals and group consumers. Moreover, in the industry, there are no buyers who are concentrated, large or buy in volume. For
example, API’s retailing business serves millions of individual buyers every year. For its wholesaling, just one type of pharmacies, independent
pharmacies, has formed over 4000 buyers to API. Similarly, PRY’s medical centres provide service to over 6 million general practitioners every year. Its ‘medical doctor’ clinical softwares are used by more than 16000 general practitioners and specialists, and over 3500 medical practices use PRY practice management software. These dispersive and large numbers of consumers indicates that buyers are low power in the industry.
Moreover, according to pharmaceuticals industry report (2009), API has been the second largest Australian wholesaler with dominating 30% market shares. Furthermore, as the expansion of its retailing business, it has become one of Australia’s leading health and beauty retailers. Similarly, PRY is also placed in a dominance position. For example, its health technology is applied by over 80% Australia’s major hospitals. These dominance positions further efficiently suppress buyers’ power. Therefore, the power of buyers is relative low in the pharmaceutical industry. That is, in the industry, the API and PRY are more powerful when they face buyers, which benefit to promote a higher profit margin for the both two companies.
2. power of suppliers
Although these two companies are in the same industry, they involve different business. API’s business includes wholesaling, retailing and manufacturing while PRY, as a services company, mainly engaged in providing medical and
Porter's Five Forces Analysis for Lizzie's Leisure Centre_企业管理_经管营销_专业资料。波特五力分析范例Overview By analyzing deep influence factors of industr...
Porter's Five Forces Analysis for Wal·mart_经管营销_PPT专区。Porter’s Five Forces Analysis for Wal-Mart --Analysis for Industry competitiveness 2012.10...
Industry Analysis Example (Porter’s Five Forces and Complementors)_资格考试/认证_教育专区。porter's reportIndustry Analysis Example (Porter’s Five Forces ...
Seminar Comment “An analysis of sustainability is similar to a five forces analysis” Specimen Outline Porter’s Five Forces model using examples from an...
Porter Five Force 27页 5财富值 Porter's Five Forces 8页 20财富值 porter's 5 force analysi... 65页 免费 Porter's Five Analysis 4页 8财富值 ...
波特五力模型(Michael Porter's Five Forces Model)_企业管理_经管营销_专业资料。经典的战略和竞争分析模型,核心部分,见解深入!专业实用!MBA...
Porter’s Five Forces Portfolio Analysis …… Strategy at the time (1970s) was focused on two dimensions of the portfolio grids …… Industry ...
Porter’s model supports analysis of the driving forces in an industry. Based on the information derived from the Five Forces Analysis, management can ...
Porter 5 force analysis_经管营销_专业资料。Porters five force analysis. it is suited to analysis your business environment.Porters...
Competing Firms in Industry Bargaining Power of Suppliers Threat of Substitute Products Ch9 Porter’s five forces-4 The purpose of Five-Forces Analysis ? ...
热门文档